check_circleStudy Completed

Contraception

EE/DRSP Phase I Bioavailability / Bioequivalence

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

55 - 75 Years
  • -

  • -

Trial summary

Enrollment Goal
37
Trial Dates
August 2009 - October 2009
Phase
Phase 1
Could I Receive a placebo
N/A
Products
Yasmin (EE30/DRSP, BAY86-5131)
Accepts Healthy Volunteer
N/A

Where to participate

StatusInstitutionLocation
Completed
SocraTec R&D Clinical WardErfurt, 99084, Germany

Trial design

Characterization of relative bioavailability and assessment of bioequivalence of Petibelle (Test) in comparison to Yarina (Reference) both containing 3 mg drospirenone and 0.03 mg ethinylestradiol in a single dose, two way crossover, open, randomized study under fasting conditions in postmenopausal women
Trial Type
Interventional
Intervention Type
N/A
Trial Purpose
N/A
Allocation
N/A
Blinding
N/A
Assignment
N/A
Trial Arms
N/A